Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 48, Issue 4, 2009, Pages 504-506

  Vihinen, Marianne K ^a,b   Kolho, Kaija Leena ^a   Jänne, Olli A ^a   Andersson, Sture ^a   Raivio, Taneli ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Crohn disease; Pediatric; Steroid; Ulcerative colitis

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; BUDESONIDE; LEPTIN; PREDNISOLONE;

ACNE; ADOLESCENT; ADULT; ARTICLE; BIOASSAY; CHILD; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DRUG ACTIVITY; ENTERITIS; FEMALE; HUMAN; LEPTIN BLOOD LEVEL; MALE; MAMMAL CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SIDE EFFECT; SYSTEMIC THERAPY; TREATMENT RESPONSE; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ADIPONECTIN; ADOLESCENT; ANIMALS; BIOLOGICAL MARKERS; CERCOPITHECUS AETHIOPS; CHILD; CHILD, PRESCHOOL; COS CELLS; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATORY BOWEL DISEASES; LEPTIN; MALE; PILOT PROJECTS;

MAMMALIA;

EID: 67650860445     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318186c495     Document Type: Article

References (15)

1. Stolte EH, van Kemenade BM, Savelkoul HF, et al. Evolution of glucocorticoid receptors with different glucocorticoid sensitivity. J Endocrinol 2006;190:17-28.
2. Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 2000;24:861-8.
3. Raff H, Bruder ED. Adiponectin and resistin in the neonatal rat: effects of dexamethasone and hypoxia. Endocrine 2006;29:341-4.
4. Uchida HA, Nakamura Y, Kaihara M, et al. Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy. Nephrol Dial Transplant 2006;21:3475-80.
5. De Vos P, Lefebvre AM, Shrivo I, et al. Glucocorticoids induce the expression of the leptin gene through a non-classical mechanism of transcriptional activation. Eur J Biochem 1998;253:619-26.
6. Vihinen MK, Raivio T, Verkasalo M, et al. Circulating glucocorti-coid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease. J Clin Gastroenterol 2008;42:1017-24.
7. Raivio T, Palvimo JJ, Kannisto S, et al. Transactivation assay for determination of glucocorticoid bioactivity in human serum. J Clin Endocrinol Metab 2002;87:3740-4.
8. Rosen J, Miner JN. The search for safer glucocorticoid receptor ligands. Endocr Rev 2005;26:452-64.
9. Kannisto S, Korppi M, Remes K, et al. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab 2000;85:652-7.
10. Wilson AM, Coutie WJ, Sims EJ, et al. The skin vasoconstrictor assay does not correlate significantly to airway or systemic responsiveness to inhaled budesonide in asthmatic patients. Eur J Clin Pharmacol 2003;58:643-7.
11. Spahn JD, Landwehr LP, Nimmagadda S, et al. Effects of gluco-corticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma. J Allergy Clin Immunol 1996;98:1073-9.
12. Molijn GJ, Spek JJ, van Uffelen JC, et al. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab 1995;80:1799-803.
13. Hausmann M, Herfarth H, Schölmerich J, et al. Glucocorticoid receptor isoform expression does not predict steroid treatment response in IBD. Gut 2007;56:1328-9.
14. De Iudicibus S, Stocco G, Martelossi S, et al. Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. Gut 2007;56:1319-21.
15. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007;380:24-30.